Wealth Way Finder
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

Wealth Way Finder

Politics

Lone Republican becomes only lawmaker to vote against crackdown on human organ trafficking

by admin May 8, 2025
May 8, 2025
Lone Republican becomes only lawmaker to vote against crackdown on human organ trafficking

A bill aimed at cracking down on the Chinese Communist Party (CCP) and its practice of forced organ harvesting passed with overwhelming support on Wednesday – though one House lawmaker voted against it.

Rep. Thomas Massie, R-Ky., was the lone Republican to oppose the Stop Forced Organ Harvesting Act, which passed 406-1.

‘It’s just another example of us trying to stick our nose in another country’s business and write their laws,’ Massie told Fox News Digital after the vote. ‘And at the end of the day, they’re gonna do what they’re gonna do, and it’s just sort of a virtue signal over here.’

Massie, a conservative libertarian, often votes against House bills that weigh in on another country’s affairs.

The Kentucky Republican pointed out that he opposed the legislation when it was up for a vote during a previous Congress.

But his pushback is also notable now given his status as an open critic of Speaker Mike Johnson, R-La., and at times, of President Donald Trump. 

The bill was introduced by Rep. Chris Smith, R-N.J., and would authorize the Secretary of State to deny U.S. passports and visitor visas to people involved in organ trafficking circles.

It would also call for sanctions on entities and individuals found to have participated in the gruesome illicit industry.

U.S. lawmakers have accused China of forced organ harvesting of its ideological opponents, including Falun Gong practitioners and Uyghur Muslims. 

This post appeared first on FOX NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
Trump halts military strikes on Houthis but expert warns Iran-backed terrorist group remains major threat
next post
Israeli military extends detention of Palestinian journalist despite acknowledging lack of evidence

Related Posts

House GOP to hear additional witness testimony from...

January 29, 2024

Eye-popping haul amid trials has Team Trump closing...

May 6, 2024

Supreme Court signals interest in hearing a major...

June 17, 2024

House GOP leaders call Schumer’s Israel comments ‘inappropriate,’...

March 15, 2024

Blinken, guitar in hand, sings ‘Rockin’ in the...

May 15, 2024

Fox News Power Rankings: Voters’ appetite for ticket-splitting...

August 12, 2024

Trump met with Laken Riley’s family backstage before...

March 10, 2024

Biden backs Harris, pushes Supreme Court ‘reform’ in...

July 25, 2024

House GOP gunning for testimony from Biden Special...

February 14, 2024

New report warns NATO’s data vulnerabilities could cost...

May 3, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,124)
    • Investing (1,915)
    • Politics (2,503)
    • World (2,513)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: wealthwayfinder.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 wealthwayfinder.com | All Rights Reserved